Stock Earnings

Question 1

Novozymes A/Sの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Novozymes A/Sの総資産は$15,195で、純profitは$305です。

Question 2

NVZMYの主要な財務比率は何ですか？

Accepted Answer

Novozymes A/Sの流動比率は3.78、純利益率は7.95、1株当たり売上高は$8.33です。

Question 3

Novozymes A/Sの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Novozymes A/S largest revenue segment is Bioenergy, at a revenue of 596,326,170 in the most earnings release.For geography, Europe, Middle East & Africa is the primary market for Novozymes A/S, at a revenue of 1,408,400,000.

Question 4

Novozymes A/Sは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Novozymes A/Sの純profitは$305です。

Question 5

Novozymes A/Sに負債はありますか？

Accepted Answer

yes、Novozymes A/Sの負債は4,019です。

Question 6

Novozymes A/Sの発行済株式数は何株ですか？

Accepted Answer

Novozymes A/Sの総発行済株式数は466.13株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	4,097	3,833	2,398	2,351	2,005	14,012
Revenue Growth (YoY)	35%	60%	2%	17%	-86%	-3%
Cost of Revenue	1,916	2,024	1,095	1,068	846	6,159
Gross Profit	2,181	1,809	1,302	1,283	1,158	7,853
Selling, General & Admin	838	659	416	400	345	2,163
Research & Development	435	333	232	221	222	1,622
Operating Expenses	1,250	1,150	704	686	631	4,243
Other Non Operating Income (Expenses)	--	-11	11	14	-1	-31
Pretax Income	746	417	523	610	526	3,521
Income Tax Expense	181	111	116	116	104	695
Net Income	564	305	405	492	421	2,825
Net Income Growth	99%	-25%	-18%	17%	-85%	-10%
Shares Outstanding (Diluted)	467.7	459.6	277.87	278.73	280.22	282.02
Shares Change (YoY)	2%	65%	0%	-1%	-1%	-2%
EPS (Diluted)	1.21	0.66	1.45	1.76	1.5	10.01
EPS Growth	96%	-54%	-17%	17%	-85%	-9%
Free Cash Flow	568	660	280	149	378	3,415
Free Cash Flow Per Share	1.21	1.43	1	0.53	1.34	12.1
Gross Margin	53.23%	47.19%	54.29%	54.57%	57.75%	56.04%
Operating Margin	22.72%	17.19%	24.93%	25.39%	26.23%	25.76%
Profit Margin	13.76%	7.95%	16.88%	20.92%	20.99%	20.16%
Free Cash Flow Margin	13.86%	17.21%	11.67%	6.33%	18.85%	24.37%
EBITDA	--	1,256	784	795	715	4,876
EBITDA Margin	--	32.76%	32.69%	33.81%	35.66%	34.79%
D&A For EBITDA	--	597	186	198	189	1,266
EBIT	931	659	598	597	526	3,610
EBIT Margin	22.72%	17.19%	24.93%	25.39%	26.23%	25.76%
Effective Tax Rate	24.26%	26.61%	22.17%	19.01%	19.77%	19.73%

Novozymes A/S (NVZMY) Price

NVZMY Stock Price Chart

NVZMY Income

Follow-Up Questions